[go: up one dir, main page]

GT200600520A - Agentes antibacterianos - Google Patents

Agentes antibacterianos

Info

Publication number
GT200600520A
GT200600520A GT200600520A GT200600520A GT200600520A GT 200600520 A GT200600520 A GT 200600520A GT 200600520 A GT200600520 A GT 200600520A GT 200600520 A GT200600520 A GT 200600520A GT 200600520 A GT200600520 A GT 200600520A
Authority
GT
Guatemala
Prior art keywords
compounds
antibacterial agents
methods
antibacterial
prepare
Prior art date
Application number
GT200600520A
Other languages
English (en)
Inventor
Timothy Allen Johnson
Debra Ann Sherry
Dennis Joseph Mcnamara
Peter Laurence Toogood
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37872452&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GT200600520(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of GT200600520A publication Critical patent/GT200600520A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

EN LA PRESENTE MEMORIA SE DESCRIBEN COMPUESTOS ANTIBACTERIANOS, MÉTODOS PARA PREPARAR LOS COMPUESTOS, COMPOSICIONES FARMACÉUTICAS QUE CONTIENEN LOS COMPUESTOS Y MÉTODOS PARA TRATAR INFECCIONES BACTERIANAS UTILIZANDO LOS COMPUESTOS Y LA COMPOSICIÓN FARMACÉUTICA.
GT200600520A 2005-12-22 2006-12-20 Agentes antibacterianos GT200600520A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US75326205P 2005-12-22 2005-12-22

Publications (1)

Publication Number Publication Date
GT200600520A true GT200600520A (es) 2007-07-17

Family

ID=37872452

Family Applications (1)

Application Number Title Priority Date Filing Date
GT200600520A GT200600520A (es) 2005-12-22 2006-12-20 Agentes antibacterianos

Country Status (12)

Country Link
US (2) US7557100B2 (es)
EP (2) EP1971612A1 (es)
JP (1) JP5513743B2 (es)
AR (1) AR058701A1 (es)
CA (1) CA2634644A1 (es)
DO (1) DOP2006000268A (es)
GT (1) GT200600520A (es)
NL (1) NL2000373C2 (es)
PE (1) PE20071137A1 (es)
TW (1) TW200734344A (es)
UY (1) UY30030A1 (es)
WO (1) WO2007072151A1 (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2529817C (en) 2003-03-10 2013-02-12 Optimer Pharmaceuticals, Inc. Novel antibacterial agents
DOP2006000268A (es) * 2005-12-22 2007-07-31 Pfizer Prod Inc Agentes antibacterianos
JP2010531868A (ja) * 2007-07-02 2010-09-30 アストラゼネカ アクチボラグ ３−スピロピリミジントリオン−キノリン誘導体と抗菌剤としてのその使用
ES2376200T3 (es) * 2007-07-06 2012-03-09 Aarhus Universitet Nanopart�?culas deshidratadas de quitosano.
US20110178064A1 (en) 2007-07-16 2011-07-21 Astrazeneca R&D Spiro condensed barbituric acid derivatives for use as antibacterial
AU2008316830B2 (en) * 2007-10-25 2016-03-17 Cempra Pharmaceuticals, Inc. Process for the preparation of macrolide antibacterial agents
US9040528B2 (en) 2008-10-14 2015-05-26 Astrazeneca Ab Chemical compounds 542
EP2350077B1 (en) * 2008-10-14 2016-01-27 Entasis Therapeutics Limited Fused, spirocyclic heteroaromatic compounds for the treatment of bacterial infections
WO2010048600A1 (en) * 2008-10-24 2010-04-29 Cempra Pharmaceuticals, Inc. Methods for treating resistant diseases using triazole containing macrolides
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
US9480679B2 (en) 2009-09-10 2016-11-01 Cempra Pharmaceuticals, Inc. Methods for treating malaria, tuberculosis and MAC diseases
HRP20160168T1 (hr) 2010-03-22 2016-03-25 Cempra Pharmaceuticals Inc Kristalne forme makrolida i njihova uporaba
EP2571506B1 (en) 2010-05-20 2017-05-10 Cempra Pharmaceuticals, Inc. Processes for preparing macrolides and ketolides and intermediates therefor
KR20130120458A (ko) 2010-09-10 2013-11-04 셈프라 파마슈티컬스, 인크. 질환을 치료하기 위한 수소결합 형성 플루오로 케토라이드
WO2013148891A1 (en) 2012-03-27 2013-10-03 Cempra Pharmaceuticals, Inc. Parenteral formulations for administering macrolide antibiotics
US8952149B2 (en) 2012-09-26 2015-02-10 Zoetis Llc Tricyclic tetrahydroquinoline antibacterial agents
US8889671B2 (en) * 2013-01-23 2014-11-18 Astrazeneca Ab Compounds and methods for treating bacterial infections
EP2968801B1 (en) 2013-03-14 2018-09-26 Cempra Pharmaceuticals, Inc. Methods for treating respiratory diseases and formulations therefor
MX356772B (es) 2013-03-15 2018-06-13 Cempra Pharmaceuticals Inc Procesos convergentes para la preparacion de agentes antibacterianos macrolidos.
SG11201609404SA (en) 2014-05-29 2016-12-29 Entasis Therapeutics Ltd Fused, spirocyclic heteroaromatic compounds for the treatment of bacterial infections
UY36851A (es) 2015-08-16 2017-03-31 Glaxosmithkline Ip Dev Ltd Compuestos para uso en aplicaciones antibacterianas
EP3658557B1 (en) 2017-07-28 2024-06-05 Takeda Pharmaceutical Company Limited Tyk2 inhibitors and uses thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5011860A (en) * 1986-04-11 1991-04-30 Schering Corporation Aryl-substituted naphthyridine and pyridopyrazine derivatives and their use in treating hyperproliferative skin diseases
DE19502178A1 (de) * 1994-01-27 1995-08-03 Hoechst Ag Thiadiazolderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Vorprodukte zur Herstellung von Flüssigkristallen
US6608081B2 (en) * 1999-08-12 2003-08-19 Ortho-Mcneil Pharmaceutical, Inc. Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterials, and related compositions and methods
CA2425283A1 (en) 2000-10-26 2002-05-02 Pfizer Products Inc. Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors
DE60208541D1 (de) * 2001-05-30 2006-03-30 Warner Lambert Co Antibakterielle mittel
AU2003228701A1 (en) 2002-04-25 2003-11-10 Bristol-Myers Squibb Company Spirobarbituric acid derivatives useful as inhibitors of matrix metalloproteases
US7208490B2 (en) * 2002-10-07 2007-04-24 Pharmacia & Upjohn Company Llc Tricyclic tetrahydroquinoline antibacterial agents
EP1888597A2 (en) 2005-05-09 2008-02-20 Warner-Lambert Company LLC Antibacterial agents
DOP2006000268A (es) * 2005-12-22 2007-07-31 Pfizer Prod Inc Agentes antibacterianos

Also Published As

Publication number Publication date
JP5513743B2 (ja) 2014-06-04
NL2000373A1 (nl) 2007-06-26
TW200734344A (en) 2007-09-16
EP2620439A1 (en) 2013-07-31
UY30030A1 (es) 2007-07-31
US7557100B2 (en) 2009-07-07
NL2000373C2 (nl) 2010-02-02
EP1971612A1 (en) 2008-09-24
US20090275536A1 (en) 2009-11-05
CA2634644A1 (en) 2007-06-28
US20070197518A1 (en) 2007-08-23
WO2007072151A1 (en) 2007-06-28
DOP2006000268A (es) 2007-07-31
AR058701A1 (es) 2008-02-20
PE20071137A1 (es) 2008-01-10
JP2009520804A (ja) 2009-05-28

Similar Documents

Publication Publication Date Title
GT200600520A (es) Agentes antibacterianos
UY31673A1 (es) "derivados heterocíclicos de urea y métodos de uso de los mismos-211"
BRPI0810064B8 (pt) compostos contendo nitrogênio tricíclico como agentes antibacterianos, composições farmacêuticas que compreendem os ditos compostos e uso dos mesmos para o tratamento de infecções bacterianas em mamíferos
NO20082191L (no) Forbindelser
UY30759A1 (es) Compuestos quimicos
CY1109916T1 (el) Βενζιμιδαζολο-θειοφαινικες ενωσεις ως plk αναστολεις
EA200901617A1 (ru) Борсодержащие молекулы небольшого размера
ECSP088763A (es) Nuevas combinaciones terapéuticas para el tratamiento de la depresión
MX2009006846A (es) Derivados de tetraciclina para el tratamiento de infecciones bacterianas, virales y parasitarias.
ECSP099634A (es) Derivados de piridazinona útiles como inhibidores de glucano sintasa
CL2008001373A1 (es) Compuestos derivados de fenilamino-benceno sustituidos; metodo de preparacion; composicion farmaceutica; kit farmceuticos; y uso de dichos compuestos en el tratamiento del cancer.
CL2008001656A1 (es) Anticuerpo anti-c3b; composicion farmaceutica que lo comprende, y su uso para prevenir o tratar un trastorno asociado con el complemento; kit que lo contiene.
EA033311B1 (ru) Производные бензоксаборола в качестве антибактериальных средств
BRPI0814593A2 (pt) Composto, composição farmacêutica que o contém e uso do composto.
CL2008001633A1 (es) Compuestos derivados de pirrolidin-3-carboxamida; composición farmacéutica; y uso comominhibidores de erk para el tratamiento del cancer.
UY32158A (es) Derivados heterociclicos y metodos de uso de los mismos
SV2009003335A (es) Formulaciones para el cancer
ECSP088440A (es) Imidazopirazinas como inhibidores de proteinquinasa
BRPI0718688A2 (pt) Composições de baixa irritação e métodos para preparar as mesmas.
GT201000047A (es) Mejoras en compuestos organicos o relacionadas con los mismos
CL2008003284A1 (es) Compuestos derivados de 4-bencilamino-1-carboxiacil-piridina, inhibidores cetp; composicion farmaceutica que los comprende; combinacion farmaceutica; y uso en el tratamiento de enfermedades metabolicas, ateroesclerosis y cardiovasculares, entre otras.
AR047928A1 (es) Derivados de tetrahidropiridoindol
BRPI0815920A2 (pt) Composto, composição farmacêutica, e, uso do composto.
PA8855001A1 (es) Monocarbamas
BRPI0922233A2 (pt) compostos, composições farmacêiticas e métodos para uso no tratamento de síndromes metabólicas.